Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Spry

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The New Zealand Medical Journal|April 28, 1993
Cervical cancer: changing trends in the Wellington regionH B Sadler, D S Lamb, G R Duncan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapyJ W Denham, S P Ackland, B Burmeister, et al.
The New Zealand Medical Journal|November 14, 1990
Results of treatment of cancer of the cervix in Wellington 1980-4D S Lamb, G R Duncan, L A Symons, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1989
Localized grade I non-Hodgkin's lymphoma: results of treatment with radiotherapy alone in 88 patientsN A Spry, D S Lamb, G Vaughan Hudson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1990
Accelerated fractionation radiotherapy for advanced head and neck cancerD S Lamb, N A Spry, A J Gray, et al.
Physics in Medicine and Biology|May 14, 2010
Comparison of DVH data from multiple radiotherapy treatment planning systemsM A Ebert, A Haworth, R Kearvell, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2006
Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancerN A Spry, L Kristjanson, B Hooton, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05)D E Roos, P C O'Brien, J G Smith, et al.
Australasian Radiology|September 7, 2000
Eligibility audits for the randomized neuropathic bone pain trial (TROG 96.05)D E Roos, S R Davis, P C O'Brien, et al.
Australasian Radiology|August 2, 2003
A prospective trial of short-fractionation radiotherapy for the palliation of liver metastasesS Bydder, N A Spry, D R H Christie, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The New Zealand Medical Journal|April 28, 1993
Cervical cancer: changing trends in the Wellington regionH B Sadler, D S Lamb, G R Duncan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapyJ W Denham, S P Ackland, B Burmeister, et al.
The New Zealand Medical Journal|November 14, 1990
Results of treatment of cancer of the cervix in Wellington 1980-4D S Lamb, G R Duncan, L A Symons, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1989
Localized grade I non-Hodgkin's lymphoma: results of treatment with radiotherapy alone in 88 patientsN A Spry, D S Lamb, G Vaughan Hudson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1990
Accelerated fractionation radiotherapy for advanced head and neck cancerD S Lamb, N A Spry, A J Gray, et al.
Physics in Medicine and Biology|May 14, 2010
Comparison of DVH data from multiple radiotherapy treatment planning systemsM A Ebert, A Haworth, R Kearvell, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2006
Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancerN A Spry, L Kristjanson, B Hooton, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05)D E Roos, P C O'Brien, J G Smith, et al.
Australasian Radiology|September 7, 2000
Eligibility audits for the randomized neuropathic bone pain trial (TROG 96.05)D E Roos, S R Davis, P C O'Brien, et al.
Australasian Radiology|August 2, 2003
A prospective trial of short-fractionation radiotherapy for the palliation of liver metastasesS Bydder, N A Spry, D R H Christie, et al.
Pageof 3